EUVIMEDEUVIMED entdecken
Crossref

Inflammatory markers in sickle cell disease during vaso-occlusive crisis

Kamal Kumar Meher, Pradeep Kumar Mohanty, Satyabrata Meher

Blood Cells, Molecules, and Diseases · 2026

DOI: 10.1016/j.bcmd.2026.102987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Blood Cells, Molecules, and Diseases, 2026. Verfasst von Kamal Kumar Meher und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Burla, Sambalpur, Odisha-768017, India. Electronic add…. Hauptthemen laut MEDLINE: Anemia, Sickle Cell, Vaso-Occlusive Crises, Inflammation. Die Arbeit nennt 34 Literaturangaben. Gefördert von: Department of Health Research, India, Ministry of Health and Family Welfare.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Sickle cell disease (SCD) is a monogenic blood disorder in which vaso-occlusive crises (VOC) are the main cause of hospitalization. Along with vascular adhesion, inflammation plays a central role in VOC. This study compared inflammatory and hematological markers in SCD patients during VOC and steady state, examined their association with outcomes such as hospital stay, acute chest syndrome (ACS), and mortality, and evaluated the impact of hydroxyurea. A total of 109 VOC patients admitted to the Department of General Medicine, VIMSAR, and 40 steady-state patients attending the outpatient clinic were included. Hematological (HbF, HbS, hemoglobin, WBC, neutrophils, platelets), biochemical (bilirubin, AST, ALT, urea, creatinine), and inflammatory markers (IL-6,CRP, ferritin, LDH, ESR) were measured. Data were analyzed using GraphPad Prism; comparisons were made by unpaired t-test and correlations by Pearson analysis. VOC patients showed significantly lower hemoglobin and higher WBC and neutrophil counts compared to controls. Inflammatory markers were markedly elevated during VOC: IL-6 (41.95 vs2.1 pg/mL), CRP (61.34 vs3.2 mg/L), ferritin (847.6 vs116.7 ng/mL), and LDH (1151.7 vs719.5 U/L). Platelet count and ESR did not differ significantly. Hydroxyurea use was associated with lower inflammatory marker levels. Inflammation strongly influences VOC severity and outcomes, and hydroxyurea mitigates this effect. Routine monitoring of inflammatory markers may support predicting course and management in SCD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anemia, Sickle CellVaso-Occlusive CrisesInflammationHumansFemaleBiomarkersMaleAdultHydroxyureaAcute Chest SyndromeAdolescentYoung AdultC-Reactive ProteinInterleukin-6

Stichwörter der Autor:innen

Inflammatory markerSickle cell diseaseVaso Occlusive Crisis

Substanzen

BiomarkersHydroxyureaC-Reactive ProteinInterleukin-6

Autor:innen und Institutionen

  • Department of Medicine, Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Burla, Sambalpur, Odisha-768017, India. Electronic address: kamalmeher109@gmail.com.
  • Department of Medicine, Veer Surendra Sai Institute of Medical Sciences and Research (VIMSAR), Burla, Sambalpur, Odisha-768017, India; Odisha Sickle Cell Project (NHM), Veer Surendra Sai Institute of Medical Science and…
  • Odisha Sickle Cell Project (NHM), Veer Surendra Sai Institute of Medical Science and Research (VIMSAR), Burla, Sambalpur, Odisha, 768017, India; Multi-disciplinary Research Unit (MRU), (ICMR-DHR, MoHFW, GoI), Veer Suren…

Förderung

  • Department of Health Research, India
  • Ministry of Health and Family Welfare

Zitieren

APA

Meher, K. K., Mohanty, P. K., & Meher, S. (2026). Inflammatory markers in sickle cell disease during vaso-occlusive crisis. Blood Cells, Molecules, and Diseases. https://doi.org/10.1016/j.bcmd.2026.102987

Vancouver

Meher KK, Mohanty PK, Meher S. Inflammatory markers in sickle cell disease during vaso-occlusive crisis. Blood Cells, Molecules, and Diseases. 2026. doi:10.1016/j.bcmd.2026.102987

BibTeX
@article{Meher2026,
  author = {Meher, Kamal Kumar and Mohanty, Pradeep Kumar and Meher, Satyabrata},
  title = {Inflammatory markers in sickle cell disease during vaso-occlusive crisis},
  journal = {Blood Cells, Molecules, and Diseases},
  year = {2026},
  doi = {10.1016/j.bcmd.2026.102987}
}
Kostenlos starten →